Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Christian Dejaco, Bastian Oppl, Paul Monach, David Cuthbertson, Simon Carette, Gary Hoffman, Nader Khalidi, Curry Koening, Carol Langford, Kathleen McKinnon-Maksimowicz, Philip Seo, Ulrich Specks, Steven Ytterberg, Peter A. Merkel, Jochen Zwerina

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Introduction: Previous studies suggest a role for eotaxin-3, TARC/CCL17 and IgG4 in newly- diagnosed patients with eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss) with highly active disease. The role of these biomarkers in relapsing disease is unclear. Methods: Serum levels of TARC/CCL17, eotaxin-3, IgG4, and IgG4/IgG ratio were determined in serum samples from a longitudinal cohort of patients with EGPA (105 visits of 25 patients). Epidemiological, clinical and laboratory data were available for all visits. Results: At the first visit, 80%of patients were using glucocorticoids and 68%additional immunosuppressive drugs. Disease flares were seen at 18 visits. The median BVAS and BVAS/WG scores at time of relapse were 4 and 2, respectively. None of the biomarkers tested were useful to discriminate between active disease and remission. Patients treated with prednisone had lower eotaxin-3 and eosinophil levels compared to patients not taking glucocorticoids irrespective of disease activity. Use of immunosuppressive agents was not associated with biomarker levels. Conclusions: Serum levels of TARC/CCL17, eotaxin-3, IgG4, and IgG4/IgG ratio do not clearly differentiate active and inactive disease in established EGPA. Defining biomarkers in EGPA remains a challenge especially during times of glucocorticoid use.

Original languageEnglish (US)
Article numbere0121737
JournalPloS one
Volume10
Issue number3
DOIs
StatePublished - Mar 26 2015

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Fingerprint Dive into the research topics of 'Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)'. Together they form a unique fingerprint.

  • Cite this

    Dejaco, C., Oppl, B., Monach, P., Cuthbertson, D., Carette, S., Hoffman, G., Khalidi, N., Koening, C., Langford, C., McKinnon-Maksimowicz, K., Seo, P., Specks, U., Ytterberg, S., Merkel, P. A., & Zwerina, J. (2015). Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss). PloS one, 10(3), [e0121737]. https://doi.org/10.1371/journal.pone.0121737